Emily Conley - 02 Feb 2022 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Director
Signature
/s/ Alexandra Balcom, attorney-in-fact
Issuer symbol
NUVL
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
4
Filing time
03 Feb 2022, 15:41:58 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 02 Feb 2022 Common Stock 40,000 $13.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest over the next three years in equal monthly installments following February 2, 2022, subject to continued service to Nuvalent, Inc. through the applicable vesting date.